Algernon Pharmaceuticals Inc (AGNPF)

[DiamondInTheRough]

Hello and welcome.

To my knowledge, they haven't stated which patients they will use for the upcoming trials. Someone correct me if they found this information.

Reason the stock price is not dropping immediately to $0.075 (Note: that's in CAD on the CNSX BTH ticker - USD ticker BLTCF it's $0.06) is because in the past they have not opened up private placements to the general public. They've strictly funded through what Cannabix Technologies calls them, "friends and family". So it's basically insiders getting a steal. Other reason for not dropping down is that we're valued at around 2 million market cap with 1 million in capital with zero toxic debt. This funding will raise the capital to 2 million so saying the company now has a 3 million market cap after funding, the PPS that would create that cap would be somewhere in the middle of the 0.075 and the current 0.15.

Silver lining of PP is they're positioning themselves to have plenty of cash going forward and the need for a private placement sends message they are reaching targets that will require additional funding (testing, etc.). Other silver lining is if the PP is only to "friends and family" and they're lining up to get in on the deal, then that sends a strong message to us as investors our forward outlook is very positive.

My only complaint with these PP's is that President Kal Malhi has a history of drawing large salaries which sucks money from the newly created capital.

IMO if they fill the PP and we still dip towards 0.075, take it as a blessing that you've been given a way to buy at the same price and load 'er up!